| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 08/25/2005 | CA2552565A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics |
| 08/24/2005 | EP1566385A1 Phosphorescent compound and electroluminescent element including the same |
| 08/24/2005 | EP1566376A1 Preparation of amino acid amides |
| 08/24/2005 | EP1565457A2 Process for synthesis bis-aryl diamidoxime compounds |
| 08/24/2005 | EP1565437A1 Dipeptidyl peptidase iv inhibiting fluorinated cyclic amides |
| 08/24/2005 | EP1565436A2 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 08/24/2005 | EP1565422A1 Vitamin d receptor modulators |
| 08/24/2005 | EP1565192A2 Method and compositions for temporarily incapaciting subjets |
| 08/24/2005 | EP1565190A2 Arylcyclopropylcarboxylic amides as potassium channel openers |
| 08/24/2005 | EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 08/24/2005 | EP1334085B1 Sulfamides as gamma-secretase inhibitors |
| 08/24/2005 | EP1163218B1 New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine |
| 08/24/2005 | EP1158980B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 08/24/2005 | EP1019075B1 Beta 2-adrenergic receptor agonists |
| 08/24/2005 | CN1659456A Filters for electronic displays |
| 08/24/2005 | CN1659131A (2-((2-alkoxy) -phenyl) -cyclopent-1-enyl) aromatic carbo and heterocyclic acid and derivatives |
| 08/24/2005 | CN1658867A Use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases |
| 08/24/2005 | CN1216056C Sulfamato hydroxamic acid metalloprotease inhibitor |
| 08/24/2005 | CN1216054C 1,4-dihydro pyridine-3,5-carboxylic-acid derivatives and preparation method thereof |
| 08/24/2005 | CN1215835C Ketone derivatives and medical use thereof |
| 08/23/2005 | US6933404 Methods of making intermediates from polyhydroxyalkanoates |
| 08/23/2005 | US6933393 Reacting methyl cyanoacetate with morphiline to form 3-morpholin-4-yl-3-oxo- propionitrile; forming salt; reacting with phenylacetic acid and 2-(2-(4-fluorophenyl)-2-oxo-1-phenyl-ethyl)-4- |
| 08/23/2005 | US6933390 Process for the arylation of aza-heterocycles with activated aromatics in presence of caesium carbonate |
| 08/23/2005 | US6933351 Process for forming polyalkenyl acylating agents |
| 08/23/2005 | US6933314 Integrin receptor inhibitors |
| 08/23/2005 | US6933307 Fungicidal phenylimine derivatives |
| 08/23/2005 | US6933261 2,4,5-Trisubstituted phenylketoenols |
| 08/18/2005 | WO2005075978A2 Time-temperature indicator based on valence isomerizations |
| 08/18/2005 | WO2005075973A2 Acousto-mechanical detection systems and methods of use |
| 08/18/2005 | WO2005075477A1 Antibacterial compounds |
| 08/18/2005 | WO2005075426A1 Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof |
| 08/18/2005 | WO2005075421A1 Bicycloester derivative |
| 08/18/2005 | WO2005075420A2 Pyrrolidine derivatives acting as ccr3-receptor antagonists |
| 08/18/2005 | WO2005075410A1 New compounds, methods for their preparation and use thereof |
| 08/18/2005 | WO2005074919A1 Diurea derivatives |
| 08/18/2005 | WO2005074686A1 N-(2-(hydroxymethyl) phenyl)-1h-pyrazole-4-carboxamide derivatives and related compounds as microbicidal active ingredients for phyto-protection and the protection of materials |
| 08/18/2005 | WO2005074598A2 Nitroxyl progenitor compounds and methods of use |
| 08/18/2005 | WO2005030794A3 Hemiasterlin derivatives and uses thereof |
| 08/18/2005 | US20050182262 Reacting an amino acid or acid salt with a halogenating agent (thionyl chloride, phosphorous pentachloride or oxalyl chloride) , to form an intermediate, reacting the intermediate with ammonia; amidation; chemical intermediate to form Levetiracetam |
| 08/18/2005 | US20050182260 Reacting substituted or unsubstituted aniline with maleic acid, succinic acid or glutaric acid in presence of polyphosporic acid; cyclization; imidation; chemical intermediates for drugs |
| 08/18/2005 | US20050182235 Methods of making intermediates from polyhydroxyalkanoates |
| 08/18/2005 | US20050182121 Thio semicarbazone and semicarbozone inhibitors of cysteine proteases and methods of their use |
| 08/18/2005 | US20050182047 Treatment of demyelinating disorders |
| 08/18/2005 | US20050182040 Benzamide derivatives |
| 08/18/2005 | US20050182032 vitamin D3 antagonist activity; treating Paget's disease, bone diseases, hypercalcemia or osteoporosis; e.g. 1 alpha,25-dihydroxyvitamin D3-26 23-lactam, N-(p-methoxy)benzyl |
| 08/18/2005 | US20050181455 aryl sulfonates and sulfates used for inhibiting bioadhesion to surfaces |
| 08/18/2005 | US20050181416 N-aryl-carbamic acid ester-derived and valeric acid ester-derived cross-linkers and conjugates, and methods for their synthesis and use |
| 08/18/2005 | DE102004001433A1 cis-Alkoxyspiro-substituierte Tetramsäure-Derivate cis-Alkoxyspiro-substituted tetramic acid derivatives |
| 08/18/2005 | CA2555313A1 Heparanase inhibitors and uses thereof |
| 08/18/2005 | CA2554771A1 Nitroxyl progenitor compounds and methods of use |
| 08/18/2005 | CA2552942A1 New compounds, methods for their preparation and use thereof |
| 08/18/2005 | CA2552928A1 Pyrrolidine derivatives acting as ccr3-receptor antagonists |
| 08/18/2005 | CA2551957A1 Acousto-mechanical detection systems and methods of use |
| 08/18/2005 | CA2551566A1 Diurea derivatives |
| 08/18/2005 | CA2497062A1 Preparation of amino acid amides |
| 08/17/2005 | EP1562949A2 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 08/17/2005 | EP1562930A2 Synthetic lactone formulations and method of use |
| 08/17/2005 | EP1562925A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/17/2005 | EP1562916A1 Methods for preparing n-arylated oxazolidinones via a copper catalyzed cross coupling reaction |
| 08/17/2005 | EP1562897A1 Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer s disease |
| 08/17/2005 | EP1562895A1 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 08/17/2005 | EP1562583A1 Atorvastatin calcium form vi or hydrates thereof |
| 08/17/2005 | EP1181274A4 Iminocyclitol inhibitors of hexoaminidase and glycosidase |
| 08/17/2005 | EP1161240B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 08/17/2005 | EP0894085B1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
| 08/17/2005 | CN1656077A Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 08/17/2005 | CN1656066A Pharmaceutical combination |
| 08/17/2005 | CN1215055C Arylsulfonamido-substituted hydroxamic acid derivatives |
| 08/16/2005 | US6930200 Mono-and di-substituted alpha-amino acid derivatives useful as raw materials for pharmaceutical and agro-chemical products |
| 08/16/2005 | US6930185 Anorectic agents; obesity; such as 4'-chloro-N-(6-((N,N-dimethylamino)methyl)-2-naphthyl)(1,1'-biphenyl)-4 -carbox-amide |
| 08/16/2005 | US6930126 Reacting oxo, esters with nitriles in the presence of hydrogen and reduction catalysts, to form heterocyclic amides, used as mixtures in drugs, cosmetics, inks, protective coatings, agriculture, stripping and cleaning compounds |
| 08/16/2005 | US6930113 For therapy and prophylaxis of sexual dysfunctios; hypertension, pulmonary hypertension, congestive heart failure, renal failure, myocardial infraction, stable, unstable and variant (Prinzmetal) angina, atherosclerosis |
| 08/16/2005 | US6930106 Inhibitors of HCV NS5B polymerase |
| 08/16/2005 | CA2342974C Methods and compositions for inhibition of angiogenesis |
| 08/11/2005 | WO2005073216A2 Hcv ns-3 serine protease inhibitors |
| 08/11/2005 | WO2005073195A2 Hcv ns-3 serine protease inhibitors |
| 08/11/2005 | WO2005073188A1 Aspartates useful as components in coating compositions and their preparation |
| 08/11/2005 | WO2005073187A1 Improved process for the preparation of amorphous atorvastatin calcium |
| 08/11/2005 | WO2005073165A1 Amide derivatives, process for production of the same, and method for application thereof as insecticide |
| 08/11/2005 | WO2005066121A3 Multifunctional amine capture agents |
| 08/11/2005 | WO2005065370A3 Soluble polymers as amine capture agents and methods |
| 08/11/2005 | WO2005053663A3 Norepinephrine reuptake inhibitors useful for treatment of cognitive failure |
| 08/11/2005 | WO2005051914A8 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 08/11/2005 | WO2005044791A3 2-halogen-6-alkyl-phenyl-substituted tetramic acid derivatives |
| 08/11/2005 | WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 08/11/2005 | US20050176961 Reacting compounds such as 7-chloro-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid with 4-Aminomethyl-3-methoxyimino-pyrrolidinium dimethanesulfonate in presence of triethylamine or a tetraC1-6alkylammonium hydroxide, and an aqueous solvent |
| 08/11/2005 | US20050176806 Use of 1-[3-hydroxy-1-adamantylamino]acetyl-2-cyano-pyrrolidine, for example with other anticholesterol drugs such as statins |
| 08/11/2005 | US20050176802 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/11/2005 | US20050176800 Preterm labor, dysmenorrhea, asthma, hypertension, fertility disorder, sexual dysfunction, undesired blood clotting, bone disorders, preeclampsia or eclampsia, or an eosinophil disorder; use with phosphodiesterase inhibitors; e.g. 7-[(2R,3R)-3-Chloro-1-(4-hydroxynonyl)-pyrrolidin-2-yl]-hept-5-enoic acid |
| 08/11/2005 | US20050176771 4-fluoro-1-({[1-(methanesulfonyl)piperidin-4-yl]amino}acetyl)pyrrolidine-2-carbonitrile; insulin-dependent diabetes (type 1 diabetes), non insulin-dependent diabetes (type 2 diabetes), insulin-resistant disorders, obesity; dipeptidyl peptidase IV-inhibiting activity |
| 08/11/2005 | US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors |
| 08/11/2005 | US20050176760 and tumors; imino-, thiocarbonyl- or hydroxyimino-substituted N-heterocyclic amide compounds such as 2-(3-aminomethylphenylamino)-N-[3-chloro-4-(2-hydroxyiminopyrrolidin-1-yl)phenyl]-2-phenylacetamide |
| 08/11/2005 | US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors |
| 08/11/2005 | US20050176731 N-[5-({(2S)-3-[(4-{4-[(4-benzylpiperidin-1-yl)carbonyl]phenyl}cyclohexyl)amino]-2-hydroxypropyl}oxy)-2-hydroxyphenyl]methanesulfonamide; beta 3 receptors agonist; gastrointestinal diseases; antiobesity, antidiabetic, cicatrizing agents, tocolytics, dysmenorrhea, antiglaucomatous; amidation |
| 08/11/2005 | US20050176727 Male erectile dysfunction; 1-(3-chlorophenyl)-3-(4-pyridin-2-yl-piperazin-1-yl)propan-1-one O-methyloxime |
| 08/11/2005 | CA2552317A1 Hcv ns-3 serine protease inhibitors |
| 08/10/2005 | EP1560939A2 Immobilization of biological molecules onto surfaces coated with monolayers |
| 08/10/2005 | EP1560812A1 Aminocyclohexyl ether compounds and uses thereof |
| 08/10/2005 | EP1560811A2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 08/10/2005 | EP1560810A1 Bifunctional phenyliso(thio)cyanates; method and intermediate products for the production thereof |